Arsenio M Fialho Selected Research

cupredoxin

2/2008	Azurin-like protein blocks invasion of Toxoplasma gondii through potential interactions with parasite surface antigen SAG1.
2/2007	Cupredoxin-cancer interrelationship: azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growth.
10/2005	Internalization of bacterial redox protein azurin in mammalian cells: entry domain and specificity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arsenio M Fialho Research Topics

Disease

19	Neoplasms (Cancer) 01/2020 - 10/2005
6	Infections 11/2021 - 08/2006
5	Breast Neoplasms (Breast Cancer) 05/2014 - 10/2005
3	Malaria 02/2008 - 08/2006
2	Glioblastoma (Glioblastoma Multiforme) 01/2012 - 08/2006
2	Acquired Immunodeficiency Syndrome (AIDS) 11/2007 - 08/2006
2	Melanoma (Melanoma, Malignant) 08/2006 - 10/2005
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Inflammation (Inflammations) 01/2017
1	Disease Progression 09/2012
1	Meningococcal Meningitis 01/2012
1	Leukemia 10/2009
1	Opportunistic Infections (Opportunistic Infection) 02/2008
1	Virus Diseases (Viral Diseases) 11/2007
1	Parasitic Diseases (Parasitic Disease) 11/2007
1	Prostatic Neoplasms (Prostate Cancer) 02/2007
1	Brain Neoplasms (Brain Tumor) 08/2006
1	Falciparum Malaria (Plasmodium falciparum Malaria) 08/2006
1	Coinfection 08/2006
1	Meningitis 08/2006
1	Parasitemia 08/2006

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 11/2021 - 08/2006
12	AzurinIBA 01/2020 - 10/2005
7	Bacterial Proteins (Bacterial Protein)IBA 01/2020 - 11/2007
6	Peptides (Polypeptides)IBA 07/2014 - 08/2006
3	Monoclonal AntibodiesIBA 07/2014 - 11/2007
3	Pharmaceutical PreparationsIBA 07/2014 - 08/2011
3	cupredoxinIBA 02/2008 - 10/2005
2	Alanine (L-Alanine)FDA Link 01/2018 - 08/2006
2	Type V Secretion SystemsIBA 01/2017 - 01/2012
2	Cadherins (E-Cadherin)IBA 05/2014 - 01/2013
2	Immunotoxins (Immunotoxin)IBA 06/2013 - 05/2010
2	EpitopesIBA 01/2012 - 08/2006
2	Antineoplastic Agents (Antineoplastics)IBA 05/2010 - 11/2007
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 02/2010 - 10/2009
1	Polysaccharides (Glycans)IBA 01/2021
1	Codon (Codons)IBA 01/2020
1	CytokinesIBA 01/2020
1	Conditioned Culture MediaIBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2018
1	Caveolin 1IBA 01/2018
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2018
1	LipidsIBA 01/2018
1	GangliosidesIBA 01/2018
1	laurdanIBA 01/2018
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 07/2014
1	Metalloproteases (Metalloproteinases)IBA 01/2013
1	Matrix Metalloproteinases (MMPs)IBA 01/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2012
1	VitronectinIBA 01/2012
1	Temozolomide (Temodar)FDA LinkGeneric 01/2012
1	EnzymesIBA 05/2010
1	Mitogen-Activated Protein Kinase Kinase Kinase 11IBA 02/2010
1	Antiparasitic Agents (Antiparasitics)IBA 11/2007
1	AntigensIBA 11/2007
1	Antiviral Agents (Antivirals)IBA 11/2007
1	EphrinsIBA 02/2007
1	Tyrosine (L-Tyrosine)FDA Link 02/2007
1	Amino Acids FDA Link 08/2006
1	Antimalarials (Antimalarial Agents)IBA 08/2006
1	Merozoite Surface Protein 1 (MSA1)IBA 08/2006
1	Cysteine (L-Cysteine)FDA Link 08/2006
1	Cytochromes c (Cytochrome c)IBA 12/2005
1	Glutathione Transferase (Glutathione S-Transferase)IBA 10/2005
1	Green Fluorescent ProteinsIBA 10/2005
1	rusticyaninIBA 10/2005

Therapy/Procedure

8	Therapeutics 09/2021 - 05/2010
1	Radiotherapy 01/2012